Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Gains from Sales and Divestitures: 2020

Historic Gains from Sales and Divestitures for Atea Pharmaceuticals (AVIR) over the last 1 years, with Dec 2020 value amounting to $20,000.

  • Atea Pharmaceuticals' Gains from Sales and Divestitures was N/A to $20,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $20,000, marking a year-over-year change of. This contributed to the annual value of $20,000 for FY2020, which is N/A change from last year.
  • As of FY2020, Atea Pharmaceuticals' Gains from Sales and Divestitures stood at $20,000.
  • Over the past 5 years, Atea Pharmaceuticals' Gains from Sales and Divestitures peaked at $20,000 during FY2020, and registered a low of $20,000 during FY2020.
  • Its 1-year average for Gains from Sales and Divestitures is $20,000, with a median of $20,000 in 2020.